𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

✍ Scribed by Mirjam Hermisson; Andrea Klumpp; Wolfgang Wick; Jörg Wischhusen; Georg Nagel; Wynand Roos; Bernd Kaina; Michael Weller


Book ID
111179321
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
318 KB
Volume
96
Category
Article
ISSN
0022-3042

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Activity of O6-methylguanine-DNA methylt
✍ Jan G. Hengstler; Berno Tanner; Lars Möller; Rolf Meinert; Bernd Kaina 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 2 views

The DNA-repair protein O 6 -methylguanine-DNA methyltransferase (alkyltransferase; MGMT) is a major determinant of resistance of cells to various alkylating cytostatic drugs. Its expression in tissues is highly variable, indicating complex regulatory mechanisms involved. Transfection-mediated expres

O6-methylguanine-DNA methyltransferase g
✍ Christine Rolhion; Frédérique Penault-Llorca; Jean-Louis Kemeny; Fabrice Kwiatko 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 169 KB 👁 2 views

Repair of cytotoxic DNA damage by O 6 -methylguanine-DNA methyltransferase (MGMT) is a potentially important factor of chemoresistance to chloroethylnitrosoureas (CE-NUs), commonly used in the treatment of glioblastoma multiforme (GBM). The value of p53 as a prognostic factor in GBMs remains unclear